Tempest Therapeutics, Inc. — Director's Dealing 2019

Jun 21, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Millendo Therapeutics, Inc. (MLND)
CIK: 0001544227
Period of Report: 2019-06-20

Reporting Person: Hedley Mary Lynne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-20	Stock Option (right to buy)	$11.59	A	12000	Acquired	2029-06-19	Common Stock (12000)	Direct

Footnotes

F1: One hundred percent (100%) of the shares subject to this option will vest on June 20, 2020, subject to the Reporting Person continuing to provide service through such date.